Traitements médicamenteux de la COVID-19 : Questions médicales fréquentes
Nom anglais: COVID-19 Drug Treatment
Descriptor UI:D000093485
Tree Number:E02.319.231
Termes MeSH sélectionnés :
Mass Screening
Questions fréquentes et termes MeSH associés
Prévention
5
#1
Les vaccins préviennent-ils la COVID-19 ?
Oui, les vaccins réduisent le risque d'infection et de formes graves de la maladie.
VaccinsPrévention
#2
Quelles mesures de prévention sont recommandées ?
Le port du masque, la distanciation sociale et le lavage des mains sont essentiels.
Mesures de préventionCOVID-19
#3
Les traitements préventifs existent-ils ?
Des traitements comme les anticorps monoclonaux peuvent être utilisés en prévention chez certains patients.
Anticorps monoclonauxPrévention
#4
Les masques chirurgicaux sont-ils efficaces ?
Oui, ils réduisent la transmission du virus en filtrant les gouttelettes respiratoires.
MasquesTransmission virale
#5
La vaccination est-elle obligatoire ?
Cela dépend des réglementations locales, mais elle est fortement recommandée.
VaccinationCOVID-19
Traitements
5
#1
Quels médicaments sont utilisés pour traiter la COVID-19 ?
Des antiviraux comme le remdesivir et des corticostéroïdes comme la dexaméthasone sont utilisés.
RemdesivirDexaméthasone
#2
Comment fonctionne le remdesivir ?
Le remdesivir inhibe la réplication du virus en bloquant l'ARN polymérase virale.
RemdesivirAntiviraux
#3
La dexaméthasone est-elle efficace pour tous les patients ?
Elle est efficace principalement chez les patients gravement malades nécessitant de l'oxygène.
DexaméthasoneCOVID-19
#4
Quels sont les effets secondaires des traitements ?
Les effets secondaires peuvent inclure des infections, des troubles gastro-intestinaux et des réactions allergiques.
Effets secondairesTraitements médicamenteux
#5
Les antibiotiques sont-ils utiles contre la COVID-19 ?
Non, les antibiotiques ne traitent pas les infections virales comme la COVID-19.
AntibiotiquesCOVID-19
Complications
5
#1
Quelles sont les complications possibles de la COVID-19 ?
Les complications incluent la pneumonie, le syndrome de détresse respiratoire et des problèmes cardiaques.
ComplicationsCOVID-19
#2
Comment la COVID-19 affecte-t-elle le cœur ?
Elle peut provoquer des myocardites et des arythmies, augmentant le risque de complications cardiaques.
MyocarditeCOVID-19
#3
Les séquelles de la COVID-19 sont-elles fréquentes ?
Oui, de nombreux patients présentent des symptômes persistants, appelés COVID long.
COVID longSéquelles
#4
La COVID-19 peut-elle affecter le système nerveux ?
Oui, des symptômes neurologiques comme des maux de tête et des troubles de l'odorat peuvent survenir.
Système nerveuxCOVID-19
#5
Quels sont les risques de thrombose ?
La COVID-19 augmente le risque de thrombose veineuse et d'embolie pulmonaire.
ThromboseCOVID-19
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les facteurs incluent l'âge avancé, les maladies chroniques et l'obésité.
Facteurs de risqueCOVID-19
#2
Les personnes immunodéprimées sont-elles plus à risque ?
Oui, elles présentent un risque accru de formes graves de la COVID-19.
ImmunodépressionCOVID-19
#3
Le sexe influence-t-il la gravité de la maladie ?
Oui, des études montrent que les hommes peuvent avoir des formes plus graves que les femmes.
SexeCOVID-19
#4
Les antécédents médicaux jouent-ils un rôle ?
Oui, des antécédents de maladies respiratoires ou cardiovasculaires augmentent le risque.
Antécédents médicauxCOVID-19
#5
L'origine ethnique influence-t-elle le risque ?
Certaines études suggèrent que certaines ethnies peuvent être plus touchées par la COVID-19.
Origine ethniqueCOVID-19
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Traitements médicamenteux de la COVID-19 : Questions médicales les plus fréquentes",
"headline": "Traitements médicamenteux de la COVID-19 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Traitements médicamenteux de la COVID-19 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-17",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Traitements médicamenteux de la COVID-19"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Traitement médicamenteux",
"url": "https://questionsmedicales.fr/mesh/D004358",
"about": {
"@type": "MedicalCondition",
"name": "Traitement médicamenteux",
"code": {
"@type": "MedicalCode",
"code": "D004358",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Traitements médicamenteux de la COVID-19",
"alternateName": "COVID-19 Drug Treatment",
"code": {
"@type": "MedicalCode",
"code": "D000093485",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Didier Raoult",
"url": "https://questionsmedicales.fr/author/Didier%20Raoult",
"affiliation": {
"@type": "Organization",
"name": "Aix-Marseille Université, IRD, APHM, MEPHI, Faculté de Médecine et de Pharmacie, 19-21 boulevard Jean Moulin, 13385 Marseille Cedex 05, France; IHU-Méditerranée Infection, 19-21 boulevard Jean Moulin, 13385 Marseille Cedex 05, France."
}
},
{
"@type": "Person",
"name": "Francesco Potì",
"url": "https://questionsmedicales.fr/author/Francesco%20Pot%C3%AC",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine and Surgery - Unit of Neurosciences, University of Parma, Parma, Italy. francesco.poti@unipr.it."
}
},
{
"@type": "Person",
"name": "Taher Entezari-Maleki",
"url": "https://questionsmedicales.fr/author/Taher%20Entezari-Maleki",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. tentezari@gmail.com."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "David Brandariz-Nuñez",
"url": "https://questionsmedicales.fr/author/David%20Brandariz-Nu%C3%B1ez",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Farmacia, Hospital Quironsalud, Barcelona, España. Electronic address: vrandariz@gmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Modeling Low Muscle Mass Screening in Hemodialysis Patients.",
"datePublished": "2022-10-21",
"url": "https://questionsmedicales.fr/article/36273447",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000526866"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fat-Free Mass Index as a Surrogate Marker of Appendicular Skeletal Muscle Mass Index for Low Muscle Mass Screening in Sarcopenia.",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36179769",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jamda.2022.08.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "The dilemma of recalling well-circumscribed masses in a screening population: A narrative literature review and exploration of Dutch screening practice.",
"datePublished": "2023-05-03",
"url": "https://questionsmedicales.fr/article/37169601",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.breast.2023.05.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-effectiveness analysis of newborn screening by tandem mass spectrometry in Shenzhen, China: value and affordability of new screening technology.",
"datePublished": "2022-08-15",
"url": "https://questionsmedicales.fr/article/35971172",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-022-08394-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The efficacy of mass screening for chronic obstructive pulmonary disease using screening questionnaires in a medical health check-up population.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36057534",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.resinv.2022.07.005"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Traitement médicamenteux",
"item": "https://questionsmedicales.fr/mesh/D004358"
},
{
"@type": "ListItem",
"position": 4,
"name": "Traitements médicamenteux de la COVID-19",
"item": "https://questionsmedicales.fr/mesh/D000093485"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Traitements médicamenteux de la COVID-19 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Traitements médicamenteux de la COVID-19",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Traitements médicamenteux de la COVID-19",
"description": "Les vaccins préviennent-ils la COVID-19 ?\nQuelles mesures de prévention sont recommandées ?\nLes traitements préventifs existent-ils ?\nLes masques chirurgicaux sont-ils efficaces ?\nLa vaccination est-elle obligatoire ?",
"url": "https://questionsmedicales.fr/mesh/D000093485?mesh_terms=Mass+Screening#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Traitements médicamenteux de la COVID-19",
"description": "Quels médicaments sont utilisés pour traiter la COVID-19 ?\nComment fonctionne le remdesivir ?\nLa dexaméthasone est-elle efficace pour tous les patients ?\nQuels sont les effets secondaires des traitements ?\nLes antibiotiques sont-ils utiles contre la COVID-19 ?",
"url": "https://questionsmedicales.fr/mesh/D000093485?mesh_terms=Mass+Screening#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Traitements médicamenteux de la COVID-19",
"description": "Quelles sont les complications possibles de la COVID-19 ?\nComment la COVID-19 affecte-t-elle le cœur ?\nLes séquelles de la COVID-19 sont-elles fréquentes ?\nLa COVID-19 peut-elle affecter le système nerveux ?\nQuels sont les risques de thrombose ?",
"url": "https://questionsmedicales.fr/mesh/D000093485?mesh_terms=Mass+Screening#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Traitements médicamenteux de la COVID-19",
"description": "Quels sont les principaux facteurs de risque ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLe sexe influence-t-il la gravité de la maladie ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'origine ethnique influence-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D000093485?mesh_terms=Mass+Screening#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Les vaccins préviennent-ils la COVID-19 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins réduisent le risque d'infection et de formes graves de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles mesures de prévention sont recommandées ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le port du masque, la distanciation sociale et le lavage des mains sont essentiels."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs existent-ils ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme les anticorps monoclonaux peuvent être utilisés en prévention chez certains patients."
}
},
{
"@type": "Question",
"name": "Les masques chirurgicaux sont-ils efficaces ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils réduisent la transmission du virus en filtrant les gouttelettes respiratoires."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle obligatoire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend des réglementations locales, mais elle est fortement recommandée."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter la COVID-19 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux comme le remdesivir et des corticostéroïdes comme la dexaméthasone sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment fonctionne le remdesivir ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le remdesivir inhibe la réplication du virus en bloquant l'ARN polymérase virale."
}
},
{
"@type": "Question",
"name": "La dexaméthasone est-elle efficace pour tous les patients ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est efficace principalement chez les patients gravement malades nécessitant de l'oxygène."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des infections, des troubles gastro-intestinaux et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils utiles contre la COVID-19 ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne traitent pas les infections virales comme la COVID-19."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la COVID-19 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, le syndrome de détresse respiratoire et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Comment la COVID-19 affecte-t-elle le cœur ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer des myocardites et des arythmies, augmentant le risque de complications cardiaques."
}
},
{
"@type": "Question",
"name": "Les séquelles de la COVID-19 sont-elles fréquentes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux patients présentent des symptômes persistants, appelés COVID long."
}
},
{
"@type": "Question",
"name": "La COVID-19 peut-elle affecter le système nerveux ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes neurologiques comme des maux de tête et des troubles de l'odorat peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de thrombose ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La COVID-19 augmente le risque de thrombose veineuse et d'embolie pulmonaire."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, les maladies chroniques et l'obésité."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles présentent un risque accru de formes graves de la COVID-19."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il la gravité de la maladie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études montrent que les hommes peuvent avoir des formes plus graves que les femmes."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou cardiovasculaires augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'origine ethnique influence-t-elle le risque ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que certaines ethnies peuvent être plus touchées par la COVID-19."
}
}
]
}
]
}
Centre for Safe Medication Practice and Research Department of Pharmacology and Pharmacy LKS Faculty of Medicine University of Hong Kong Hong Kong Special Administrative Region, 1/F, Jockey Club Building for Interdisciplinary Research, 5 Sassoon Road Pokfulam Hong Kong SAR China.
Publications dans "Traitements médicamenteux de la COVID-19" :
Department of Computer Science Faculty of Engineering University of Hong Kong Hong Kong Special Administrative Region, CB303, Chow Yei Ching Building Pokfula Hong Kong SAR China.
Publications dans "Traitements médicamenteux de la COVID-19" :
Centre for Safe Medication Practice and Research Department of Pharmacology and Pharmacy LKS Faculty of Medicine University of Hong Kong Hong Kong Special Administrative Region, 1/F, Jockey Club Building for Interdisciplinary Research, 5 Sassoon Road Pokfulam Hong Kong SAR China.
Publications dans "Traitements médicamenteux de la COVID-19" :
Department of Computer Science Faculty of Engineering University of Hong Kong Hong Kong Special Administrative Region, CB303, Chow Yei Ching Building Pokfula Hong Kong SAR China.
Publications dans "Traitements médicamenteux de la COVID-19" :
Department of Computer Science Faculty of Engineering University of Hong Kong Hong Kong Special Administrative Region, CB303, Chow Yei Ching Building Pokfula Hong Kong SAR China.
Publications dans "Traitements médicamenteux de la COVID-19" :
Department of Computer Science and Engineering Southern University of Science and Technology 1088 Xueyuan Avenue, Nanshan District Shenzhen Guangdong 518055 China.
Publications dans "Traitements médicamenteux de la COVID-19" :
Division of Epidemiology and Biostatistics School of Public Health University of Hong Kong Hong Kong Special Administrative Region, 21 Sassoon Road Pokfulam Hong Kong SAR China.
Publications dans "Traitements médicamenteux de la COVID-19" :
Division of Infectious Diseases Department of Medicine LKS Faculty of Medicine University of Hong Kong Hong Kong Special Administrative Region, 102 Pokfulam Road Hong Kong SAR China.
Publications dans "Traitements médicamenteux de la COVID-19" :
Computed tomography (CT) can accurately measure muscle mass, which is necessary for diagnosing sarcopenia, even in dialysis patients. However, CT-based screening for such patients is challenging, espe...
Hemodialysis patients (n = 619) who had undergone abdominal CT screening were divided into the development (n = 441) and validation (n = 178) groups. PMI was manually measured using abdominal CT image...
Of all subjects, 226 (37%) were diagnosed with low muscle mass using PMI. A predictive model for low muscle mass was calculated using ten variables: each grip strength, sex, height, dry weight, primar...
Our results facilitate skeletal muscle screening in hemodialysis patients, assisting in sarcopenia prophylaxis and intervention decisions....
We aimed to examine the relationship between the fat-free mass index (FFMI; FFM/height...
Cross-sectional study....
This study included 1313 adults (women, 33.6%) aged 40-87 years (mean age, 55 ± 10 years) from the WASEDA'S Health Study....
Body composition was measured using multifrequency BIA and DXA. Low muscle mass was defined according to the criteria of the Asian Working Group for Sarcopenia 2019....
BIA-measured FFMI showed strong positive correlations with both BIA- (r = 0.96) and DXA-measured (r = 0.95) ASMIs. Similarly, in the subgroup analysis according to age and obesity, the FFMI was correl...
The FFMI showed a strong positive correlation with BIA- and DXA-measured ASMIs, regardless of age and obesity. The FFMI could be a useful simple surrogate marker of the ASMI for low muscle mass screen...
In Dutch breast cancer screening, solitary, new or growing well-circumscribed masses should be recalled for further assessment. This results in cancers detected but also in false positive recalls, esp...
A systematic literature search was performed using PubMed. In addition, follow-up data were retrieved on all 8860 recalled women in a Dutch screening region from 2014 to 2019....
Based on 15 articles identified in the literature search, we found that probably benign well-circumscribed masses that were kept under surveillance had a positive predictive value (PPV) of 0-2%. New o...
To recognize malignancies presenting as well-circumscribed masses, identifying solitary, new or growing lesions is key. This information is missing at initial screening since prior examinations are no...
Newborn screening (NBS) can prevent inborn errors of metabolism (IEMs), which may cause long-term disability and even death in newborns. However, in China, tandem mass spectrometry (MS/MS) screening h...
A Markov model was built to estimate the cost and quality-adjusted life-years (QALYs) of different screening programs. We compared PKU screening using traditional immunofluorescence (IF) with the othe...
The incremental cost-effectiveness ratio (ICER) of detecting all 12 IEMs in the national program is 277,823 RMB per QALY, below three times per capita GDP in Shenzhen. MS/MS screening in Shenzhen can ...
We conclude that the newborn screening using MS/MS in Shenzhen is cost-effective, and the budget affordable for the Shenzhen government. Two concepts for selecting the IEMs to be detected are also pre...
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease, highlighting the need for efficient screening strategies to identify patients with COPD. However, there is little e...
In this cross-sectional study, we originally investigated the efficacy of mass screening for COPD among community residents in the aforementioned region using two COPD screening questionnaires....
From July 2018 through January 2019, 688 participants were enrolled. COPD was diagnosed using the Global Initiative for the Chronic Obstructive Lung Disease criteria. Twenty-one patients were newly di...
Mass screening for COPD using screening questionnaires, particularly the COPD-PS questionnaire, might be useful to identify the early stages of COPD in a medical health check-up population....
Although the study design for identifying specific disease associations using a health insurance database has been well-established, few studies explore unknown comorbidities. We conducted a series of...
Gastric cancer is an inflammation-related cancer triggered by Helicobacter pylori infection. Understanding of the natural disease course has prompted the hypothesis that gastric cancer can be prevente...
The early detection of symptoms and rapid testing are the basis of an efficient screening strategy to control COVID-19 transmission. The olfactory dysfunction is one of the most prevalent symptom and ...
The main goal of this study was to examine the relationship between exposure to mass media health campaign massages and the uptake of non-communicable diseases (NCDs) screening services in Ghana and w...
Updated data on the seroprevalences of hepatitis B and C viruses (HBV, HCV) are required to enable the adaptation of control strategies. In this study, we aimed to: (i) estimate the seroprevalences of...
From October 2020 to October 2022, a mass screening campaign was conducted in 10 cities across Burkina Faso. Individuals of all ages and genders who consented to participate were screened for viral ma...
A total of 15,650 participants were enrolled in the study. Of these, 51.4% were women and the age range was from 1 to 97 years. All participants were screened for HBsAg and 7,507 were also screened fo...
The prevalence of HBV and HCV infections remains high in Burkina Faso. Prevention strategies, including initial mass screening with rapid diagnostic tests and vaccination, need to be intensified....